Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-01-10 @ 4:11 AM
Study NCT ID:
NCT03170518
Status:
COMPLETED
Last Update Posted:
2025-04-25
First Post:
2017-05-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-21
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-20
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-26
First Submit QC Date:
None
Study First Post Date:
2017-05-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-10
Results First Submit QC Date:
None
Results First Post Date:
2025-03-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-03-12
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-04-24
Last Update Post Date:
2025-04-25
Last Update Post Date Type:
ACTUAL